US5149782A
(en)
*
|
1988-08-19 |
1992-09-22 |
Tanox Biosystems, Inc. |
Molecular conjugates containing cell membrane-blending agents
|
US5171563A
(en)
*
|
1988-09-30 |
1992-12-15 |
Neorx Corporation |
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
|
US5155210A
(en)
*
|
1990-09-11 |
1992-10-13 |
Brunswick Corporation |
Methods of conjugating actinomycin d
|
AU8730691A
(en)
*
|
1990-09-28 |
1992-04-28 |
Neorx Corporation |
Polymeric carriers for release of covalently linked agents
|
US5776458A
(en)
*
|
1990-12-05 |
1998-07-07 |
Pharmacia & Upjohn S.P.A. |
Anthracycline-conjugates
|
FR2676058B1
(fr)
*
|
1991-04-30 |
1994-02-25 |
Hoechst Lab |
Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
|
AU701529B2
(en)
*
|
1994-04-05 |
1999-01-28 |
Purdue Research Foundation |
NADH oxidase as a target in diagnosis and therapy
|
US20030119724A1
(en)
*
|
1995-11-22 |
2003-06-26 |
Ts`O Paul O.P. |
Ligands to enhance cellular uptake of biomolecules
|
AU4907897A
(en)
|
1996-10-11 |
1998-05-11 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
US20030215421A1
(en)
*
|
1999-07-21 |
2003-11-20 |
Mcdonald John R. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
US7157418B1
(en)
|
1998-07-22 |
2007-01-02 |
Osprey Pharmaceuticals, Ltd. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
US6299860B1
(en)
*
|
1998-10-15 |
2001-10-09 |
Fluoro Probe, Inc. |
Method for viewing diseased tissue located within a body cavity
|
US6652836B2
(en)
|
1998-10-15 |
2003-11-25 |
Fluoroprobe, Inc. |
Method for viewing tumor tissue located within a body cavity
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
US7112337B2
(en)
|
1999-04-23 |
2006-09-26 |
Alza Corporation |
Liposome composition for delivery of nucleic acid
|
EP1173221A2
(en)
*
|
1999-04-23 |
2002-01-23 |
Alza Corporation |
Releasable linkage and compositions containing same
|
ATE340592T1
(de)
*
|
1999-04-23 |
2006-10-15 |
Alza Corp |
Konjugate enthaltend eine spaltbare bindung zur anwendung in einem liposom
|
US7303760B2
(en)
|
1999-04-23 |
2007-12-04 |
Alza Corporation |
Method for treating multi-drug resistant tumors
|
CN1110322C
(zh)
*
|
1999-07-21 |
2003-06-04 |
中国医学科学院医药生物技术研究所 |
单克隆抗体Fab'-平阳霉素偶联物及其抗肿瘤作用
|
WO2001062968A2
(en)
*
|
2000-02-25 |
2001-08-30 |
General Atomics |
Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods
|
AU2001250898A1
(en)
*
|
2000-03-17 |
2001-10-03 |
The Salk Institute For Biological Studies |
Compositions associated with complex formation
|
US6610504B1
(en)
|
2000-04-10 |
2003-08-26 |
General Atomics |
Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
|
EP1282714A2
(en)
*
|
2000-05-10 |
2003-02-12 |
Bristol-Myers Squibb Company |
Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
|
EP1355672A2
(en)
|
2000-12-01 |
2003-10-29 |
Cell Works Inc. |
Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
EP1392359B2
(en)
|
2001-05-11 |
2013-03-13 |
Ludwig Institute for Cancer Research Ltd. |
Specific binding proteins and uses thereof
|
MXPA03011094A
(es)
|
2001-05-31 |
2004-12-06 |
Medarex Inc |
Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
US7384760B2
(en)
*
|
2004-04-30 |
2008-06-10 |
General Atomics |
Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase
|
US7517903B2
(en)
*
|
2004-05-19 |
2009-04-14 |
Medarex, Inc. |
Cytotoxic compounds and conjugates
|
US7691962B2
(en)
*
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
US7541330B2
(en)
*
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
RU2007110846A
(ru)
*
|
2004-08-26 |
2008-10-10 |
Николас Пайрамал Индия Лимитед (In) |
Пролекарства, включающие новые биодеградируемые линкеры
|
AU2006214031A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Medarex, Inc. |
Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
|
US7714016B2
(en)
*
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
BRPI0617546A2
(pt)
*
|
2005-09-26 |
2011-07-26 |
Medarex Inc |
conjugado de fÁrmaco-anticorpo, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula de tumor, mÉtodo para retardar ou interromper o crescimento de um tumor em um sujeito mamÍfero e composto
|
PL1940789T3
(pl)
|
2005-10-26 |
2012-04-30 |
Squibb & Sons Llc |
Metody i związki do otrzymywania analogów cc-1065
|
CA2627190A1
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
Medarex Llc |
化學鏈接劑與可裂解基質以及其之綴合物
|
US9090693B2
(en)
|
2007-01-25 |
2015-07-28 |
Dana-Farber Cancer Institute |
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
|
CN101616911A
(zh)
*
|
2007-02-21 |
2009-12-30 |
梅达莱克斯公司 |
具有单个氨基酸的化学连接物及其偶联物
|
US9023356B2
(en)
|
2007-03-15 |
2015-05-05 |
Ludwig Institute For Cancer Research Ltd |
Treatment method using EGFR antibodies and SRC inhibitors and related formulations
|
US8956825B2
(en)
|
2007-05-24 |
2015-02-17 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Intranuclear protein transduction through a nucleoside salvage pathway
|
ES2609915T3
(es)
|
2007-08-14 |
2017-04-25 |
Ludwig Institute For Cancer Research Ltd. |
Anticuerpo monoclonal 175 direccionado al receptor de EGF y derivados y usos del mismo
|
JP6035009B2
(ja)
|
2007-08-22 |
2016-11-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
活性化可能な結合ポリペプチドおよびその同定方法ならびに使用
|
WO2009039207A1
(en)
*
|
2007-09-19 |
2009-03-26 |
Oncofluor, Inc. |
Method for imaging and treating organs and tissues
|
CN102143970B
(zh)
|
2008-05-27 |
2017-02-08 |
健赞股份有限公司 |
α‑促黑素细胞激素的肽类似物
|
KR101413480B1
(ko)
|
2008-12-05 |
2014-07-10 |
아브락시스 바이오사이언스, 엘엘씨 |
Sparc 결합 펩티드와 이들의 용도
|
EP3543256A1
(en)
|
2009-01-12 |
2019-09-25 |
Cytomx Therapeutics Inc. |
Modified antibody compositions, methods of making and using thereof
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
RU2011138951A
(ru)
|
2009-02-23 |
2013-03-27 |
Сайтомкс Терапьютикс, Инк. |
Пропротеины и способы их применения
|
EP2438090B1
(en)
|
2009-05-28 |
2016-07-06 |
The United States Government as Represented by the Department of Veterans Affairs |
Amino acid sequences which enhance peptide conjugate solubility
|
US8871744B2
(en)
|
2010-07-21 |
2014-10-28 |
B & G Partyers, LLC |
Compounds and methods for selectively targeting tumor-associated mucins
|
GB201012410D0
(en)
|
2010-07-23 |
2010-09-08 |
Medical Res Council |
Intracellular immunity
|
RU2606016C2
(ru)
|
2011-01-14 |
2017-01-10 |
Редвуд Байосайнс, Инк. |
Меченые альдегидом полипептиды иммуноглобулина и способы их применения
|
GB201202268D0
(en)
|
2012-02-09 |
2012-03-28 |
Medical Res Council |
Intracellular immunity
|
AU2012395148B2
(en)
|
2012-11-24 |
2016-10-27 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
WO2015127685A1
(en)
|
2014-02-28 |
2015-09-03 |
Hangzhou Dac Biotech Co., Ltd |
Charged linkers and their uses for conjugation
|
US11053302B2
(en)
|
2014-11-05 |
2021-07-06 |
Nanyang Technological University |
Stabilized and autonomous antibody VH domain
|
CA2991973C
(en)
|
2015-07-12 |
2021-12-07 |
Suzhou M-Conj Biotech Co., Ltd. |
Bridge linkers for conjugation of a cell-binding molecule
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
CN109071634A
(zh)
|
2016-04-26 |
2018-12-21 |
R.P.谢勒技术有限责任公司 |
抗体偶联物及其制备和使用方法
|
US20190330317A1
(en)
|
2016-06-15 |
2019-10-31 |
Yale University |
Anti-guanosine antibody as a molecular delivery vehicle
|
JP2019518040A
(ja)
|
2016-06-15 |
2019-06-27 |
イェール ユニバーシティーYale University |
腫瘍に対して標的化されるナノキャリアの抗体媒介性自触反応的送達
|
KR102459469B1
(ko)
|
2016-11-14 |
2022-10-26 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
US20210054102A1
(en)
|
2018-02-01 |
2021-02-25 |
Yale University |
Compositions and methods for enhancing nuclear translocation
|
EP4182475A2
(en)
|
2020-07-17 |
2023-05-24 |
Onena Medicines S.L. |
Antibodies against lefty proteins
|
EP4079327A1
(en)
*
|
2021-04-22 |
2022-10-26 |
Centaurus Polytherapeutics |
Payloads for drug-conjugates and their use for treating cancer
|
WO2023010060A2
(en)
|
2021-07-27 |
2023-02-02 |
Novab, Inc. |
Engineered vlrb antibodies with immune effector functions
|
WO2023056450A1
(en)
|
2021-09-30 |
2023-04-06 |
Yale University |
Compositions and methods for the treatment of autosomal dominant polycystic kidney disease and other diseases having upregulated mtor activity
|
WO2024050524A1
(en)
|
2022-09-01 |
2024-03-07 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for directing apolipoprotein l1 to induce mammalian cell death
|
WO2024064752A2
(en)
|
2022-09-20 |
2024-03-28 |
Yale University |
Compositions of wet adhesives derived from vibrio cholerae biofilm adhesins and methods thereof
|